Literature DB >> 33649861

Anticancer effects and potential mechanisms of ginsenoside Rh2 in various cancer types (Review).

Haibo Zhang1, Song Park2, Hai Huang1, Eungyung Kim1, Junkoo Yi3, Seong-Kyoon Choi2, Zaeyoung Ryoo4, Myoungok Kim1.   

Abstract

Ginsenoside Rh2 (G‑Rh2) is a natural bioactive product derived from Panax ginseng Meyer (P. ginseng). G‑Rh2 exhibits anticancer activity in various human cancer cell lines both in vitro and in vivo by modulating several signaling pathways, such as those of PDZ‑binding kinase/T‑LAK cell‑originated protein kinase, phosphatidylinositol 3‑kinase, protein kinase B, mammalian target of rapamycin, epidermal growth factor receptor, p53, and reactive oxygen species. Moreover, G‑Rh2 could effectively reverse drug resistance and enhance therapeutic effects in cancer therapy. This review summarizes the chemical properties, in vitro and in vivo anticancer activity, and underlying molecular mechanisms of G‑Rh2 to facilitate cancer chemoprevention studies.

Entities:  

Year:  2021        PMID: 33649861     DOI: 10.3892/or.2021.7984

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

1.  Ginsenoside 20(S)-Rh2 promotes cellular pharmacokinetics and intracellular antibacterial activity of levofloxacin against Staphylococcus aureus through drug efflux inhibition and subcellular stabilization.

Authors:  Xiao-Yang Chen; Fei Qian; Yao-Yao Wang; Yan Liu; Yuan Sun; Wei-Bin Zha; Kun Hao; Fang Zhou; Guang-Ji Wang; Jing-Wei Zhang
Journal:  Acta Pharmacol Sin       Date:  2021-08-30       Impact factor: 6.150

Review 2.  The Untapped Potential of Ginsenosides and American Ginseng Berry in Promoting Mental Health via the Gut-Brain Axis.

Authors:  Tristan St-Laurent; Riadh Hammami
Journal:  Nutrients       Date:  2022-06-17       Impact factor: 6.706

3.  Network Pharmacology-Based Prediction and Verification of Ginsenoside Rh2-Induced Apoptosis of A549 Cells via the PI3K/Akt Pathway.

Authors:  Chao Song; Yue Yuan; Jing Zhou; Ziliang He; Yeye Hu; Yuan Xie; Nan Liu; Lei Wu; Ji Zhang
Journal:  Front Pharmacol       Date:  2022-05-04       Impact factor: 5.988

4.  Ginsenoside Rh2 upregulates long noncoding RNA STXBP5-AS1 to sponge microRNA-4425 in suppressing breast cancer cell proliferation.

Authors:  Jae Eun Park; Hyeon Woo Kim; Sung Hwan Yun; Sun Jung Kim
Journal:  J Ginseng Res       Date:  2021-08-27       Impact factor: 6.060

Review 5.  Biotransformation, Pharmacokinetics, and Pharmacological Activities of Ginsenoside Rd Against Multiple Diseases.

Authors:  Jing Li; Qingxia Huang; Yao Yao; Peng Ji; E Mingyao; Jinjin Chen; Zepeng Zhang; Hongyu Qi; Jiaqi Liu; Zhaoqiang Chen; Daqing Zhao; Lei Zhou; Xiangyan Li
Journal:  Front Pharmacol       Date:  2022-07-19       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.